Alert: Major Price Advance (8/13/24)-Lifecore Biomedical Inc (NASDAQ: LFCR).

out_logo_500#25222.jpg

Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 11.2% on 8/13/24. The shares closed at $6.04. However, below average trading volume at 82% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 14.8% during the last week.

out_mm#25222.jpg

Current PriceTarget Research Rating

LFCR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.

Lifecore Biomedical is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*